Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00145704 · ClinicalTrials.gov registry record · NA
Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
A NA study, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00145704 is a NA study that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 6 participants.
The verdict
NCT00145704, a NA study, was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this project is to evaluate the hypothesis that bisphosphonate treatment given to growth hormone deficient patients (regardless of current growth hormone replacement therapy status and without changing that status) significantly increases total body bone mineral density during an eighteen month period of treatment combined with calcium and Vitamin D when compared to calcium and Vitamin D treatment alone.
Interventions
- DIETARY_SUPPLEMENT Vitamin D supplement
- DIETARY_SUPPLEMENT Calcium
- DRUG bisphosphonate therapy (risedronate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2002-06 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00145704
The ClinicalTrials.gov registry entry for NCT00145704 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vitamin D supplement is the first listed.
NCT00145704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00145704 about?
NCT00145704 is a clinical study titled "Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density". The purpose of this project is to evaluate the hypothesis that bisphosphonate treatment given to growth hormone deficient patients (regardless of current growth hormone replacement therapy status and without changing that status) significantly increases total body bone mineral density during an eigh...
What is the current status of trial NCT00145704?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2002-06. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00145704?
The interventions under investigation include: Vitamin D supplement (DIETARY_SUPPLEMENT), Calcium (DIETARY_SUPPLEMENT), bisphosphonate therapy (risedronate) (DRUG).
Who is sponsoring clinical trial NCT00145704?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.